Gross Evidence for Tumor at Autopsy Was Detected in All Syngeneic EL4 Recipients, But Not in IL-12–Protected Allogeneic EL4 Recipients
| Group (n) . | Tumor at Autopsy . |
|---|---|
| . | (no. with tumor/total evaluated) . |
| Syn BMT +/− IL-12 (9/9) | 0/18 |
| Allo BMT (25) | 0/15 |
| Allo BMT + IL-12 (26) | 0/12 |
| Syn BMT + EL4 (15) | 12/13 |
| Syn BMT + EL4 + IL-12 (15) | 13/13 |
| Allo BMT + EL4 (8) | 0/5* |
| Allo BMT + EL4 + IL-12 (26) | 0/15 |
| Group (n) . | Tumor at Autopsy . |
|---|---|
| . | (no. with tumor/total evaluated) . |
| Syn BMT +/− IL-12 (9/9) | 0/18 |
| Allo BMT (25) | 0/15 |
| Allo BMT + IL-12 (26) | 0/12 |
| Syn BMT + EL4 (15) | 12/13 |
| Syn BMT + EL4 + IL-12 (15) | 13/13 |
| Allo BMT + EL4 (8) | 0/5* |
| Allo BMT + EL4 + IL-12 (26) | 0/15 |
All animals died of GVHD by 8 days posttransplant.